• Biotech Breakthroughs – The Future of GLP-1s

  • Jun 12 2024
  • Length: 23 mins
  • Podcast

Biotech Breakthroughs – The Future of GLP-1s

Listen for free

View show details

  • Summary

  • Biotech equity research analysts Andy Hsieh and Matt Phipps join group head Tim Lugo to discuss the latest developments in GLP-1s for diabetes and obesity treatment, including the emergence of oral therapies and the profound weight loss results seen in recent data sets. The conversation also covers the commercial trajectory of drugs like semaglutide and tirzepatide, the potential for market growth, and the challenges of patient retention and reimbursement, concluding with a look at the future of the field, including the exploration of new mechanisms and the focus on quality of weight loss.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Economics Personal Finance
Show more Show less

What listeners say about Biotech Breakthroughs – The Future of GLP-1s

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available